ArticleMolecular pharmaceutics2017

Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria.

Shoukath Sulthana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.